Boothbay Fund Management, LLC Axogen, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.8 - $16.0 $154,554 - $281,008	-17,563 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.23 - $21.72 $47,441 - $67,657	3,115 Added 21.56%	17,563 $277,000
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $44,678 - $58,985	2,510 Added 21.03%	14,448 $312,000
Q1 2021 May 17, 2021	SELL	$17.18 - $22.6 $198,617 - $261,278	-11,561 Reduced 49.2%	11,938 $242,000
Q4 2020 Feb 12, 2021	BUY	$11.5 - $17.96 $270,238 - $422,042	23,499 New	23,499 $421,000

179

36.2M

82.6K

1.1K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $738M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.